STBK yields 16.53% · PFE yields 6.13%● Live data
📍 STBK pulled ahead of the other in Year 1
Combined, STBK + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of STBK + PFE for your $10,000?
Studio Financial Holdings, Inc. operates as the holding company for Studio Bank that provides various financial services in the United States. It offers commercial banking services, including commercial checking, and commercial savings and money market accounts; interest on lawyers trust accounts; cash concentration, remote capture, preauthorized automated clearing house debits and filtering, wire transfers, zero balance and automated sweep, account reporting and reconciliation, and positive pay services; term and bridge loans, revolving lines of credit, land development loans, construction and development lines of credit, and other commercial loans; and commercial credit cards. The company also provides personal banking services comprising personal checking and personal savings accounts; mortgages and other personal loan accounts; and personal credit cards. In addition, it offers tech and startup banking services; and mortgage and home loan options, as well as home equity lines of credit and home equity installment loans. The company operates through its offices in Davidson County, Tennessee; and a loan production office in Williamson County, Tennessee. Studio Financial Holdings, Inc. was founded in 2017 and is based in Nashville, Tennessee.
Full STBK Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.